Metformin monotherapy can achieve up to a 1.3% reduction in hemoglobin A1c after approximately six months.

“so again metformin is typically first line I suspect part of that has to do with cost but I also believe it has to do with efficacy I mean metformin monotherapy is pretty robust uh it depends on the study but it's up to 1.3 percent reduction in hemoglobin A1c after about six months”